Showing 1 - 10 of 21
Novo Nordisk and Embassy of Denmark Donate 430,000 THB to Flood Relief Efforts in Southern Thailand
Published on 11/12/2025
» Novo Nordisk Pharma Thailand Ltd. (“Novo Nordisk”) and the Embassy of Denmark in Bangkok have donated 430,000 THB (around 86,000 DKK) to the Diabetes Association of Thailand to support relief efforts following the major floods in southern Thailand.
Thammasat, Novo Nordisk Partner to Advance Clinical Research
Published on 12/11/2025
» Thammasat University Hospital, the Faculty of Medicine, Thammasat University, and Novo Nordisk Pharma (Thailand) Ltd. have signed a Memorandum of Understanding (MOU) to expand clinical trials at the hospital, building on their previous collaboration to tackle Diabetes and Obesity. This new agreement aims to drive positive change in the management and treatment of cardio-metabolic diseases in Thailand.
Bangkok advances urban health agenda with landmark mou
Published on 12/11/2025
» A major step forward in Bangkok’s public health journey was marked by the signing of a Memorandum of Understanding (MOU) to establish “Bangkok, City for Better Health” — a collaborative initiative between the Bangkok Metropolitan Administration (BMA), the Royal Danish Embassy Bangkok, and Novo Nordisk Pharma Thailand Ltd. The ceremony, held at the Embassy of Denmark, also unveiled the “Childhood Obesity Curriculum”, a tangible outcome of the project’s early success.
Denmark joins anti-urban obesity drive
News, Poramet Tangsathaporn, Published on 08/11/2025
» The Bangkok Metropolitan Administration (BMA), the Danish Embassy, and Novo Nordisk Pharma Thailand have signed a Memorandum of Understanding (MoU) to promote healthier urban lifestyles and combat obesity under the "Bangkok, City for Better Health" initiative.
Unlock and Rock: Empowering Haemophilia Families
Published on 24/10/2025
» In a continued effort to enhance healthcare awareness and support for rare diseases, Chonburi Hospital, in collaboration with Novo Nordisk Pharma (Thailand) Ltd. (“Novo Nordisk”), hosted the “Unlock and Rock Haemophilia” event. The initiative aimed to raise awareness and strengthen understanding of haemophilia among children, patients, and their families, while engaging the haemophilia community in Eastern Thailand through the Thai Hemophilia Patient Club.
Novo Nordisk Completes Landmark Diabetes Affordability Project
Published on 31/07/2025
» Bangkok, - Novo Nordisk Pharma (Thailand) Ltd. (Novo Nordisk) today announced the successful completion of the Affordability Project in Thailand as part of its ongoing commitment to drive change in diabetes in the country. This transformative initiative was launched in collaboration with the Department of Medical Services, Ministry of Public Health. Over the past three years, the project has actively addressed the rising diabetic problems in Thailand through a public-private partnership with the Thai state-owned Rajavithi Hospital, Institute of Medical Research & Technology Assessment and Bureau of Medical System Supervision as the project’s main implementor.
Novo Nordisk Brings Cities for Better Health to Bangkok
Published on 11/07/2025
» Bangkok, July 11, 2025 — Following a visit to Copenhagen, Denmark, to collaborate on enhancing urban health, the Bangkok Metropolitan Administration (BMA) and Novo Nordisk will launch the Cities for Better Health (CBH) programme in Bangkok in 2025.
Novo Nordisk Thailand and HSRI MoU Enhances Clinical Research Standards
Published on 02/06/2025
» The rapid advancement of medical technology is playing a vital role in enhancing the health system and quality of life for individuals in Thailand. Clinical research is essential in facilitating the development of new medications, devices, and treatment methodologies for complex and rare diseases. Reports indicate that nations such as China, the United States, various African countries, and others in Asia are significantly increasing their investments in medical research and development (R&D). Thailand has been classified as an ‘opportunity tier’, possessing a large number of patients ready for treatment. This presents researchers with numerous opportunities for trial volunteers, making Thailand more competitive compared to Europe and the US, where research costs tend to be higher.
Thammasat, Novo Nordisk Unite for Holistic Diabetes, Obesity Care
Published on 28/05/2025
» Thammasat University Hospital, in collaboration with Novo Nordisk Pharma (Thailand) Ltd. (“Novo Nordisk”), announced a collaboration titled “Partnership Project for the Transition into the Fourth Decade of Thammasat University Hospital: Beat Obesity Beat Diabetes” at the Thammasat University Hospital. The public-private partnership aims to enhance holistic patient care and expand equitable access for all.
Novo Nordisk Launches Campaign to Tackle Obesity
Published on 20/05/2025
» Novo Nordisk Pharma (Thailand) Ltd. is advancing its commitment to sustainable weight management among Thais through the launch of the “From My Weight to My Heart” campaign, aimed at reducing the risk of cardiovascular diseases and non-communicable diseases (NCDs)—key global health challenges. The campaign debuted with an inspirational panel featuring leading public figures.